{"id":"W2600127085","doi":"10.1111/dom.12958","title":"Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Sitagliptin; Medicine; Internal medicine; Endocrinology; Placebo; Metformin; Glycated hemoglobin; Type 2 diabetes; Glucagon receptor; Blood pressure; Lipid profile; Glucagon-like peptide 1 receptor; Glucagon; Diabetes mellitus; Insulin; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004541866,0.0003023109,0.0007881254,0.000124917,0.0001222495,0.0002904169,0.0001697249,0.0003047588,0.001191329],"category_scores_gemma":[0.0005586495,0.0001286909,0.0003473438,0.000170744,0.0002140891,0.0001968692,0.0001035035,0.0005789232,0.0002426498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001742151,"about_ca_system_score_gemma":0.000205334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002256221,"about_ca_topic_score_gemma":0.0006803176,"domain_scores_codex":[0.9998289,0.00007564396,0.00002305862,0.00002146873,0.00003372159,0.00001723926],"domain_scores_gemma":[0.9996444,0.00008226935,0.0001655873,0.00001365866,0.00001667702,0.00007738381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3949275,0.01248497,0.09099688,0.001740663,0.002600479,0.0009213393,0.0002374059,0.001592258,0.1493307,0.0001803643,0.003341081,0.3416464],"study_design_scores_gemma":[0.162428,0.4159557,0.3845055,0.0002054008,0.00162014,0.004369156,0.0002276033,0.004319256,0.0212588,0.0002605775,0.004776401,0.00007348844],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958877,0.003136392,0.0001095222,0.000157124,0.00003062155,0.00003740695,0.00007776562,0.00002398231,0.0005394911],"genre_scores_gemma":[0.9977118,0.001224933,0.0003220892,0.0002599683,0.00008866184,0.00004338027,0.0001666819,0.000003700195,0.0001787282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001191329,"threshold_uncertainty_score":0.003985345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008540022634781116,"score_gpt":0.2100609367524394,"score_spread":0.2015209141176582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}